# A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT06949267** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Acute Graft-versus-Host Disease

## Interventions

- **BIOLOGICAL:** iMSC
- **COMBINATION_PRODUCT:** conventional aGVHD prophylaxis

## Key facts

- **NCT ID:** NCT06949267
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06949267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06949267, "A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06949267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*